Printer Friendly

Research and Markets: Alcoholism - Pipeline Review, Q2 2011.

DUBLIN -- Research and Markets ( has announced the addition of Global Markets Direct's new report "Alcoholism - Pipeline Review, Q2 2011" to their offering.

'Alcoholism - Pipeline Review, Q2 2011', provides an overview of the Alcoholism therapeutic pipeline. This report provides information on the therapeutic development for Alcoholism, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Alcoholism. 'Alcoholism - Pipeline Review, Q2 2011' is built using data and information sourced from a proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources


* A snapshot of the global therapeutic scenario for Alcoholism.

* A review of the Alcoholism products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

* Coverage of products based on various stages of development ranging from discovery till registration stages.

* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

* Coverage of the Alcoholism pipeline on the basis of therapeutic class, route of administration and molecule type.

* Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.

* Key discontinued pipeline projects.

* Latest news and deals relating to the products.

Key Topics Covered:

* List of Tables

* List of Figures

* Introduction

* Global Markets Direct Report Coverage

* Alcoholism Overview

* Therapeutics Development

* An Overview of Pipeline Products for Alcoholism

* Alcoholism Therapeutics under Development by Companies

* Alcoholism Therapeutics under Investigation by Universities/Institutes

* Late Stage Products

* Comparative Analysis

* Mid Clinical Stage Products

* Comparative Analysis

* Early Clinical Stage Products

* Comparative Analysis

* Pre-Clinical Stage Products

* Comparative Analysis

* Alcoholism Therapeutics - Products under Development by Companies

* Alcoholism Therapeutics - Products under Investigation by Universities/Institutes

* Companies Involved in Alcoholism Therapeutics Development

* and much more...

For more information visit
COPYRIGHT 2011 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2011 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jul 6, 2011
Previous Article:Epoch Announces Assets Under Management of $17.1 Billion.
Next Article:AppNeta Announces Higher Education Discount Program for Instant-Value Network Performance Management Solution.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters